/u/ipostsomethingtoday's posts
Longeveron Inc. (NASDAQ: LGVN) is actively seeking partnerships and funding opportunities to advance its Alzheimer's Disease program.
Mark as read: Add to a list
LGVN Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference®
Mark as read: Add to a list
Mark as read: Add to a list
Longeveron Inc. (NASDAQ: LGVN) is actively seeking partnerships and funding opportunities to advance its Alzheimer's Disease program.
Mark as read: Add to a list
Mark as read: Add to a list